Leisha A. Emens

Leisha A. Emens

Oncology
401 N Broadway St
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications

SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development.

SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development.

Journal: Journal for immunotherapy of cancer
Published: May 26, 2025

A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy.

A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy.

Journal: Journal for immunotherapy of cancer
Published: February 03, 2025

A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer.

A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer.

Journal: Gynecologic oncology
Published: December 17, 2024

Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 28, 2024

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).

Journal: Nature communications
Published: October 18, 2024

Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer.

Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 23, 2024

Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.

Journal: bioRxiv : the preprint server for biology
Published: June 03, 2024

Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.

Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.

Journal: Journal for immunotherapy of cancer
Published: April 24, 2024

Advances and challenges in cancer immunoprevention and immune interception.

Advances and challenges in cancer immunoprevention and immune interception.

Journal: Journal for immunotherapy of cancer
Published: February 29, 2024

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.

Journal: Cancer research communications
Published: February 09, 2024

Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer.

Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer.

Journal: bioRxiv : the preprint server for biology
Published: January 08, 2024

A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition.

A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition.

Journal: Science advances
Published: June 30, 2023
Showing 1-12 of 121

Last Updated: 09/26/2026